SEI Trust Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$122K Buy
1,563
+436
+39% +$28.1K ﹤0.01% 1431
2014
Q2
$71K Sell
1,127
-603
-35% -$35.8K ﹤0.01% 1511
2014
Q1
$116K Buy
1,730
+1,313
+315% +$102K ﹤0.01% 1392
2013
Q4
$27K Buy
+417
New +$24.9K ﹤0.01% 1604

Other funds holding ALNY

SEI Trust Company's ALNY Position: Q3 2014 in Review

SEI Trust Company increased its Alnylam Pharmaceuticals (ALNY) stake by 39% in Q3 2014, buying an estimated $28.1K and bringing the position to 1,563 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

SEI Trust Company first reported a position in ALNY in Q4 2013 and has held it in 4 quarters since. 186 funds tracked by Wall St. Rank hold ALNY as of Q3 2014.

  • SEI Trust Company held 1,563 shares of Alnylam Pharmaceuticals worth $122K as of Q3 2014.
  • SEI Trust Company bought 436 Alnylam Pharmaceuticals shares in Q3 2014, an estimated $28.1K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1431 holding.
  • SEI Trust Company first reported a position in Alnylam Pharmaceuticals in Q4 2013 and has held it in 4 quarters since.
  • 186 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.